Press Releases

Indica Labs’ HALO AP® platform achieves CE-IVD certification for use in primary diagnosis

Indica Labs has announced that following ISO13485 certification, HALO AP® has received a CE Mark for use in primary diagnosis within the European Economic Area, Switzerland, and the UK.

Curebase and Persephone Biosciences Partner in Clinical Trial of Colorectal Cancer Among Diverse Populations

Curebase and Persephone Biosciences Partner in Clinical Trial of Colorectal Cancer Among Diverse Populations

Pharmaron acquires commercial API manufacturing facility in the United Kingdom from Recipharm

Pharmaron Beijing Co., Limited, has announced today that it has acquired Aesica Pharmaceuticals Limited ("The Cramlington Site") from Recipharm group. This move will help Recipharm streamline operations in line with its strategic goals and better align with customers' needs.

Recipharm announces sale of Fontaine-lès-Dijon site to Astrea

Recipharm has today announced the sale of the solid dose manufacturing site at Fontaine-lès-Dijon, France, to Astrea Pharma. The move is a positive step in streamlining Recipharm's operations and consolidating its position as a top five global Contract Development and Manufacturing Organisation.

Rho Acquires European CRO Dokumeds, Expanding Global Reach and Capabilities

Rho Acquires European CRO Dokumeds, Expanding Global Reach and Capabilities Dokumeds brings complementary specialties and multinational footprint in Europe and beyond Research Triangle Park, NC – December 8, 2021 – Rho, a full-service contract research organization (CRO) with a proven track record of drug development success, today announced that it has acquired Dokumeds, a privately-held European CRO. Established in 1995 and headquartered in Riga, Latvia, Dokumeds has 10 offices and is active across multiple continents. Terms were not disclosed.

Sixth Acquisition Extends Veranex Lead in MedTech Industry Services

Veranex, the only global, tech-enabled product development services provider focused on the medical technology industry, today announced its latest acquisition, Worrell, further expanding its offerings and geographic reach. As one integrated company, Veranex delivers compelling strategic, operational, and financial benefits by combining the skills and expertise needed for developing breakthrough medical technologies from concept to commercialization.

IDDI celebrates its 30th anniversary this year

IDDI celebrates its 30th anniversary

ATMPS and Assurea LLC launch strategic collaboration for advanced therapy supply chain

Curebase Named to the 2021 CB Insights Digital Health 150 -- List of Most Innovative Digital Health Startups

Curebase recognized for achievements in Clinical Trials Tech

Hoth Therapeutics Sign API and Drug Product Contracts with WuXi STA to Advance Manufacturing of HT-KIT

HiRO and CluePoints Partnership Offers Market-Leading RBQM Opportunities in China

King of Prussia, PA, December 13, 2021: Harvest Integrated Research Organization (HiRO), a Shanghai-based Clinical Research Organization (CRO), has collaborated with CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software, to provide Risk-Based Quality Management (RBQM) expertise and technology in the Chinese region. This market-leading partnership will increase clinical trial efficiency and reduce deviation and bias to obtain accurate patient outcomes.

CCD specialist, Atik Cameras launches the TE-77 advanced scientific solution, using new CCD technology from Teledyne e2v

Atik Cameras has launched the first in its advanced imaging solutions, the TE-77 CCD sensor.

Inceptua receives approval of marketing authorization transfer of Apealea® (paclitaxel micellar) for the treatment of ovarian cancer

Inceptua Group has announced that the European Commission (EC) and the UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved the transfer of the marketing authorization for Apealea® (paclitaxel micellar) from Oasmia Pharmaceutical AB to Inceptua AB

Deplesin® Strategic Partnerships Meet a Huge Unmet Need for Bipolar Disorder Patients, While Emphasizing Corporate Commitments to Innovation and Increasing Partner Revenue

Lo.Li. Pharma International has announced a new strategic partnering plan for their new product, Deplesin®.

IDDI Becomes a Medidata Rave EDC Partner

IDDI Becomes a Medidata Rave EDC Partner

Calyx Partnership with Top 5 CRO Extended through 2024

Clinical trial management system delivers heightened data security, open connectivity, and improved trial efficiencies

Panthera leads the way in the UK with specialist research sites for NASH and NAFLD studies

Panthera leads the way in the UK with specialist research sites for NASH and NAFLD studies.

Curebase Technology Key to metaMe Health’s FDA Clearance of Regulora

Clinical research for Regulora was successfully completed using Curebase’s decentralized clinical trial (DCT) technology and services.

NOORIK BIOPHARMACEUTICALS ANNOUNCES THE SIGNING OF A DEVELOPMENT CONTRACT WITH THE FEDERAL GOVERNMENT OF SWITZERLAND TO DEVELOP AMBRISENTAN AS A TREATMENT FOR SEVERE COVID-19

Noorik Biopharmaceuticals Ltd has signed a contract with the Federal Government of Switzerland to develop ambrisentan as a treatment for patients with severe COVID-19.

Novel Concepts Medical Groundbreaking Medicine Successfully Disrupted COVID-19 Spike Protein Attachment into Host Cells, Intended to Stop Omicron

Novel Concepts Medical (NCM) has announced the successful testing of its plant-based formulations for the treatment of SARS-CoV-2, the virus responsible for the COVID-19 pandemic.